Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

GliaMed Inc
Profile last edited on: 9/2/2023      CAGE:       UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2002
First Award
2003
Latest Award
2006
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

3960 Broadway 3rd Floor
New York, NY 10032
   (212) 543-0444
   dweinstein@gliamed.com
   www.gliamed.com
Location: Single
Congr. District: 13
County: New York

Public Profile

GliaMed, Inc. is a biotechnology research and development company that has created a platform of compounds designed for the treatment of Multiple Sclerosis, Alzheimer’s, Parkinson’s and other neurodegenerative diseases, as well as the treatment of malignant brain tumors, stroke and other brain and spinal cord trauma

Extent of SBIR involvement

User Avatar
Phase I Awards
2
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$553,880
Phase II Dollars
$0
Total Awarded
$553,880

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
15-19

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2006 1 NIH $362,512
Project Title: Optimization of GMAK to treat glioblastoma multiforme
2003 1 NIH $191,368
Project Title: Refinement of GM1416-a Drug to Treat Neurodegeneration

Key People / Management

  Jefferey Freed -- President

  David E Weinstein -- CEO

Company News

There are no news available.